1887

Abstract

Introduction:

When diagnosing pneumonia (PJP), the clinical suspicion must be confirmed by laboratory tests. PJP is rarely described in patients with idiopathic CD4 lymphocytopenia (ICL), a rare T‐cell deficiency of unknown origin with persistently low levels of CD4 T‐cells (<300 µl or <20 % of total lymphocytes) but repeated negative human immunodeficiency virus (HIV) tests. We retrospectively analysed a case of an ICL patient with severe PJP associated with multiple opportunistic infections (OIs). We also reviewed the literature since 1986.

Case presentation:

A laboratory‐confirmed case of PJP associated with invasive candidiasis and cytomegalovirus infection was reported in an ICL patient. Despite early treatment, the patient died of respiratory failure under polymicrobial pneumonia. According to the literature, the mortality rate of ICL patients is 10.4 % (33/316). In ICL patients, the risk of OI is 83.2 % (263/316), with viral infections being the most prevalent (58.2 %, 184/316), followed by fungal infections (52.2 %, 165/316) and mycobacterial infections (15.5 %, 49/316). Dysimmunity is reported in 15.5 % (49/316) of ICL patients. Among the fungal infections, cryptococcal infections are the most prevalent (24.1 %, 76/316), followed by candidiasis (15.5 %, 49/316) and PJP (7.9 %, 25/316).

Conclusions:

The high risk of OIs underlines the importance of more vigorous preventative actions in hospitals. The response to therapy and the detection of early relapse of PJP may be monitored by several laboratory tests including quantitative PCR. It is essential to treat the ICL and to follow the guidelines concerning therapy and prophylaxis of OIs as given to HIV patients.

  • This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/).
Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.T00017
2014-12-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/1/4/jmmcr003434.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.T00017&mimeType=html&fmt=ahah

References

  1. Ahmad D.S, Esmadi M, Steinmann W.C. 2013; Idiopathic CD4 Lymphocytopenia: spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J Med 3:37–47 [CrossRef]
    [Google Scholar]
  2. Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, Molina J, Derouin F, Menotti J. 2011; Real‐time PCR assay‐based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect 17:1531–1537 [CrossRef]
    [Google Scholar]
  3. Azie N, Neofytos D, Pfaller M, Meier‐Kriesche H.U, Quan S.P, Horn D. 2012; The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. Diagn Microbiol Infect Dis 73:293–300 [CrossRef]
    [Google Scholar]
  4. Baroudjian B, Viguier M, Battistella M, Beneton N, Pagès C, Gener G, Bégon E, Bachelez H. 2014; Psoriasis associated with idiopathic CD4+ T‐cell lymphopenia: a regulatory T cells defect?. Br J Dermatol 171:186–189 [CrossRef]
    [Google Scholar]
  5. Castro J.G, Morrison‐Bryant M. 2010; Management of Pneumocystis jirovecii pneumonia in HIV infected patients: current options, challenges and future directions. HIV AIDS (Auckl) 2:123–134
    [Google Scholar]
  6. Chen S.C, Slavin M.A, Heath C.H, Playford E.G, Byth K, Marriott D, Kidd S.E, Bak N, Currie B. other authors 2012; Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis 55:789–798 [CrossRef]
    [Google Scholar]
  7. Chumpitazi B.F.F, Flori P, Kern J‐B, Brenier‐Pinchart M‐P, Hincky‐Vitrat V, Brion J‐P, Thiebaut‐Bertrand A‐T, Minet C, Maubon D. other authors 2011; Characteristics and clinical relevance of the quantitative touch‐down major‐surface‐glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia. Med Mycol 49:704–713
    [Google Scholar]
  8. Chumpitazi B.F.F, Lebeau B, Faure‐Cognet, Hamidfar‐Roy R, Timsit J.F, Pavese P, Thiebaut‐Bertrand A, Quesada J.L, Pelloux H. other authors 2014; Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis. Med Mycol 52:462–471 [CrossRef]
    [Google Scholar]
  9. Cohen K, Hadary R, Shilo L, Shabun A, Kimchi O, Kitay‐Cohen Y. 2012; Liver injury in idiopathic CD4+ T‐cell lymphocytopenia. Harefuah 151:688–691
    [Google Scholar]
  10. Colomba C, Rubino R, Di Carlo P, Mammina C, Bonura C, Siracusa L, Titone L, Saporito L. 2012; Probable disseminated Mycobacterium abscessus subspecies bolletii infection in a patient with idiopathic CD4+ T lymphocytopenia: a case report. J Med Case Rep 6:277 [CrossRef]
    [Google Scholar]
  11. Cushion M.T, Stringer J.R. 2010; Stealth and opportunism: alternative lifestyles of species in the fungal genus Pneumocystis . Annu Rev Microbiol 64:431–452 [CrossRef]
    [Google Scholar]
  12. Denis B, Guiguet M, de Castro N, Mechaï F, Revest M, Mahamat A, Gregoire G.M, Lortholary O, Costagliola D. 2014; Critical importance of long‐term adherence to care in HIV infected patients in the cART era: new insights from Pneumocystis jirovecii pneumonia cases over 2004–2011 in the FHDH‐ANRS CO4 cohort. PLoS One 9:e94183 [CrossRef]
    [Google Scholar]
  13. Duncan R.A, von Reyn C.F, Alliegro G.M, Toossi Z, Sugar A.M, Levitz S.M. 1993; Idiopathic CD4+ T‐lymphocytopenia – four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med 328:393–398 [CrossRef]
    [Google Scholar]
  14. Esteves F, Medrano F.J, de Armas Y, Wissmann G, Calderón E.J, Matos O. 2014; Pneumocystis and pneumocystosis: first meeting of experts from Latin‐American and Portuguese‐speaking countries – a mini‐review. Expert Rev Anti Infect Ther 12:545–548 [CrossRef]
    [Google Scholar]
  15. Fricker‐Hidalgo H, Lebeau B, Pelloux H, Grillot R. 2004; Use of the BACTEC 9240 System with Mycosis‐IC/F blood culture bottles for detection of fungemia. J Clin Microbiol 42:1855–1856 [CrossRef]
    [Google Scholar]
  16. Ghannad M.S, Solgi G, Hashemi S.H, Zebarjady‐Bagherpour J, Hemmatzadeh A, Hajilooi M. 2013; Herpes simplex virus encephalitis in Hamadan, Iran. Iran J Microbiol 5:272–277
    [Google Scholar]
  17. Gonzalez‐Estrada A, Fernandez J. 2013; PCP: thinking beyond HIV. BMJ Case Rep pii,bcr2013201687 [CrossRef]
    [Google Scholar]
  18. Helweg‐Larsen J, Benfield T, Atzori C, Miller R.F. 2009; Clinical efficacy of first‐ and second‐line treatments for HIV‐associated Pneumocystis jirovecii pneumonia: a tri‐centre cohort study. Antimicrob Chemother 64:1282–1290 [CrossRef]
    [Google Scholar]
  19. Kaczmarski R.S, Webster A.D, Moxham J, Davison F, Sutherland S, Mufti G.J. 1994; CD4+ lymphocytopenia due to common variable immunodeficiency mimicking AIDS. J Clin Pathol 47:364–366 [CrossRef]
    [Google Scholar]
  20. Kelly M.J, Benjamin L.A, Cartwright K, Ajdukiewicz K.M, Cohen D.B, Menyere M, Galbraith S, Guiver M, Neuhann F. other authors 2012; Epstein–Barr virus coinfection in cerebrospinal fluid is associated with increased mortality in Malawian adults with bacterial meningitis. J Infect Dis 205:106–110 [CrossRef]
    [Google Scholar]
  21. Khot P.D, Fredricks D.N. 2009; PCR‐based diagnosis of human fungal infections. Expert Rev Anti Infect Ther 7:1201–1221 [CrossRef]
    [Google Scholar]
  22. Luo L, Li T. 2008; Idiopathic CD4 lymphocytopenia and opportunistic infection – an update. FEMS Immunol Med Microbiol 54:283–289 [CrossRef]
    [Google Scholar]
  23. Marukutira T, Huprikar S, Azie N, Quan S.P, Meier‐Kriesche H.U, Horn D.L. 2014; Clinical characteristics and outcomes in 303 HIV‐infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study. HIV AIDS (Auckl) 6:39–47 [CrossRef]
    [Google Scholar]
  24. Masur H, Brooks J.T, Benson C.A, Holmes K.K, Pau A.K, Kaplan J.E. 2014; Prevention and treatment of opportunistic infections in HIV‐infected adults and adolescents: updated guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 58:1308–1311 [CrossRef]
    [Google Scholar]
  25. Matsuyama W, Tsurukawa T, Iwami F, Wakimoto J, Mizoguchi A, Kawabata M, Osame M. 1998; Two cases of idiopathic CD4+ T‐lymphocytopenia in elderly patients. Intern Med 37:891–895 [CrossRef]
    [Google Scholar]
  26. McBath A, Stafford R, Antony S.J. 2014; Idiopathic CD4 lymphopenia associated with neuroinvasive West Nile disease: case report and review of the literature. J Infect Public Health 7:170–173 [CrossRef]
    [Google Scholar]
  27. Miller R.F, Huang L, Walzer P.D. 2013; Pneumocystis pneumonia associated with human immunodeficiency virus. Clin Chest Med 34:229–241 [CrossRef]
    [Google Scholar]
  28. Ollé‐Goig J.E, Ramírez J, Cervera C, Miró J.M. 2012; Profound reduction of CD4+ lymphocytes without HIV infection: two cases from the horn of Africa. Afr Health Sci 12:331–333
    [Google Scholar]
  29. Pappas P.G. 2013; Cryptococcal infections in non‐HIV‐infected patients. Trans Am Clin Climatol Assoc 124:61–79
    [Google Scholar]
  30. Régent A, Kluger N, Bérezné A, Lassoued K, Mouthon L. 2012; Démarche diagnostique devant une lymphopénie: quand penser à la lymphopénie CD4+ idiopathique?. Rev Med Interne 33:628–634 [CrossRef]
    [Google Scholar]
  31. Régent A, Autran B, Carcelain G, Cheynier R, Terrier B, Charmeteau‐De Muylder B, Krivitzky A, Oksenhendler E, Costedoat‐Chalumeau N. other authors 2014; Idiopathic CD4 lymphocytopenia: clinical and immunologic characteristics and follow‐up of 40 patients. Medicine (Baltimore) 93:61–72 [CrossRef]
    [Google Scholar]
  32. Roux A, Gonzalez F, Roux M, Mehrad M, Menotti J, Zahar J.R, Tadros V.X, Azoulay E, Brillet P.Y. other authors 2014; Update on pulmonary Pneumocystis jirovecii infection in non‐HIV patients. Med Mal Infect 44:185–198 [CrossRef]
    [Google Scholar]
  33. Sage E.K, Noursadeghi M, Evans H.E, Parker S.J, Copas A.J, Edwards S.G, Miller R.F. 2010; Prognostic value of C‐reactive protein in HIV‐infected patients with Pneumocystis jirovecii pneumonia. Int J STD AIDS 21:288–292 [CrossRef]
    [Google Scholar]
  34. Sinicco A, Maiello A, Raiteri R, Sciandra M, Dassio G, Zamprogna C, Mecozzi B. 1996; Pneumocystis carinii in a patient with pulmonary sarcoidosis and idiopathic CD4+ T lymphocytopenia. Thorax 51:446–447 [CrossRef]
    [Google Scholar]
  35. Smith D.K, Neal J.J, Holmberg S.D. 1993; Unexplained opportunistic infections and CD4+ T‐lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T‐lymphocytopenia Task Force. N Engl J Med 328:373–379 [CrossRef]
    [Google Scholar]
  36. Thoden J, Potthoff A, Bogner J.R, Brockmeyer N.H, Esser S, Grabmeier‐Pfistershammer K, Haas B, Hahn K, Härter G. other authors 2013; Therapy and prophylaxis of opportunistic infections in HIV‐infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection 41:(Suppl.2)S91–S115 [CrossRef]
    [Google Scholar]
  37. Tu G.W, Ju M.J, Xu M, Rong R.M, He Y.Z, Xue Z.G, Zhu T.Y, Luo Z. 2013; Combination of caspofungin and low‐dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients. Nephrology (Carlton) 18:736–742 [CrossRef]
    [Google Scholar]
  38. Venzor J, Hua Q, Bressler R.B, Miranda C.H, Huston D.P. 1997; Behçet’s‐like syndrome associated with idiopathic CD4+ T‐lymphocytopenia, opportunistic infections, and a large population of TCRαβ+ CD4 CD8 T cells. Am J Med Sci 313:236–238 [CrossRef]
    [Google Scholar]
  39. Walzer P.D. 2013; The ecology of Pneumocystis: perspectives, personal recollections, and future research opportunities. J Eukaryot Microbiol 60:634–645 [CrossRef]
    [Google Scholar]
  40. Zicklerova I, Uzlikova M, Nohynkova E. 2012; Molecular evidence of Pneumocystis jirovecii reinfection in a haemato‐oncology patient. Scand J Infect Dis 44:705–707 [CrossRef]
    [Google Scholar]
  41. Zonios D, Sheikh V, Sereti I. 2012; Idiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells. Arthritis Res Ther 14:222 [CrossRef]
    [Google Scholar]
  42. Zonios D.I, Falloon J, Huang C.Y, Chaitt D, Bennett J.E. 2007; Cryptococcosis and idiopathic CD4 lymphocytopenia. Medicine (Baltimore) 86:78–92 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.T00017
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.T00017
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error